Dubai Science Park hosts 4,000+ professionals across pharmaceutical and medical device sectors.
An AI-first approach to drug discovery is the anchor.
Pharmaville →
https://t.co/gW8hJrLrGS
#LifeSciences#Dubai
CDMO location strategy is where policy meets execution.
2025 US executive order → FDA review streamlining → Bora's Maple Grove + Baltimore + Rockville network.
Pharmaville editorial →
https://t.co/jjkQJZyGEv
#CDMO#Manufacturing
Rockville, Maryland anchors the BioHealth Capital Region.
Third-largest US biopharma cluster. Unparalleled proximity to NIH + FDA. AstraZeneca, GSK and Samsung Biologics all operate in the metro.
Pharmaville →
https://t.co/6e6VZAKtXE
#LifeSciences#Rockville
Bora Pharmaceuticals operates a CDMO network across the US, Canada and Taiwan.
Recent acquisitions: Maple Grove (Minneapolis) + Baltimore aseptic fill-finish. Announced: MacroGenics biologics site in Rockville, MD.
Xtalks interview →
https://t.co/hplD5eZcg2
#CDMO#Pharma
Princeton, New Jersey anchors the Medicine Chest of the World corridor.
Bristol Myers Squibb HQ. Genmab. Princeton University. Princeton West Innovation Campus. Cell + gene therapy + genomics + computational biology.
Pharmaville →
https://t.co/9dg2aXimFM
#Biotech#NewJersey
São Paulo hosts the headquarters of Brazil's pharma giants Eurofarma, EMS and Aché, alongside a massive concentration of multinational biopharma operations.
The industrial engine of Latin America's life sciences.
Pharmaville →
https://t.co/aFpkHYOUZp
#LifeSciences#Brazil
For emerging biotech in specialty indications, the strategic moat is not the molecule.
It is site-level operational discipline. Incannex's OSA program is the working example.
Pharmaville editorial →
https://t.co/USt8jNqPjI
#Biotech#OSA
Elraglusib + gemcitabine/nab-paclitaxel improved median OS to 10.1 months vs 7.2 months for chemo alone in metastatic pancreatic cancer.
Nature Medicine.
Xtalks interview →
https://t.co/mNdirnenQu
#Oncology#PancreaticCancer
About 936M adults 30-69 worldwide have mild-to-severe OSA. ~425M with moderate-to-severe.
Incannex's IHL-42X: oral fixed-dose dronabinol + acetazolamide. Positive RePOSA Phase II. FDA Fast Track.
Xtalks interview →
https://t.co/3cRLbJH3I0
#OSA#Biotech
Hyderabad accounts for ~1/3 of the world's vaccine production and 40% of India's drug production.
Dr. Reddy's, Aurobindo, plus 600+ life sciences companies.
Pharmaville →
https://t.co/OO5qfPQP0K
#LifeSciences#India#Vaccines
The Weizmann Institute of Science, headquartered in Rehovot, has birthed blockbuster therapies across oncology and multiple sclerosis.
One of the most productive academic drug discovery engines globally.
Pharmaville →
https://t.co/82hbH7876Y
#LifeSciences#Israel
"The ecosystem has reached a level of maturity where it is no longer about the potential. It is rather about the proof."
Annija Veinšteina, LIAA, on Latvia in a new Xtalks interview.
Pharmaville →
https://t.co/7ZZ8GuhY28
#LifeSciences#Latvia
Latvia's 2026 merger of LIOS and BMC creates the Baltics' largest integrated life sciences research center.
Drug discovery + genomics + biobanking under one national institute.
Pharmaville →
https://t.co/nUqMUMo61v
#LifeSciences#Latvia
Shanghai hosts 92M+ ft² of biopharma R&D space. Suzhou hosts ~3,800 biopharma firms.
The harder question for NMPA and SIP is staying visible to sponsors who have not yet shortlisted China.
Pharmaville →
https://t.co/JYExYdR5Ze
#FDI#AsiaPacific
Denmark led the EEA in 2023 for per-capita commercial clinical trial starts (2.00 per 100,000).
The Danish Clinical Quality Program runs 85 clinical registries integrating nationwide health data.
Pharmaville →
https://t.co/khGZSeAbyb
#LifeSciences#Denmark#ClinicalTrials
For emerging biotech, location is no longer one place.
It is a portfolio of places. HQ in one city, manufacturing in another, trials at the best site for the indication.
Pharmaville editorial →
https://t.co/D01INrdcqJ
#Biotech#LifeSciences
London hosts 19 of the world's top 20 pharma companies.
2,400+ life sciences firms. 34,800 jobs. 2,600 active clinical studies. The deepest integrated big-pharma + academic + NHS ecosystem in Europe.
Pharmaville →
https://t.co/urmmKk77Fa
#LifeSciences#London#Pharma
"There are two major factors to think about... One, which is really the most important by far, is talent."
CERo Therapeutics CEO Chris Ehrlich on why talent remains the dominant biotech location factor.
Xtalks interview →
https://t.co/ifw6g0UTcp
#Biotech#Oncology
Samsung Biologics operates the world's largest biopharma capacity (784,000 L) one hour from Seoul.
The harder question for KOTRA and MFDS is staying visible to sponsors who have not yet shortlisted Korea.
Pharmaville →
https://t.co/NSbpbbOSVV
#FDI#AsiaPacific